Stocks News

LAST PRICE
294.0100
TODAY'S CHANGE (%)
Trending Up8.5700 (3.0024%)

Bid / Lots
265.8000/ 1
Ask / Lots
305.3000/ 1
Open / Previous Close
288.1700 / 285.4400
Day Range
Low 288.0000
High 294.8500
52 Week Range
Low 261.5900
High 431.7900
Volume
192,707
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 8, 2024
- UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating, from 10:19AM ET on Wednesday May 08, 2024 by MT Newswires
  10:19AM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: BIO
  10:19 AM EDT, 05/08/2024 (MT Newswires) -- Bio-Rad Laboratories (BIO) has an average outperform rating and price target range of $365 to $441, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research f...
- DJ Bio-Rad Laboratories Is Maintained at Buy by UBS, from 9:37AM ET on Wednesday May 08, 2024 by Dow Jones
  9:37AM ET on Wednesday May 08, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BIO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 08, 2024 09:37 ET (13:37 GMT)
- RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420, from 8:27AM ET on Wednesday May 08, 2024 by MT Newswires
  8:27AM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: BIO
  08:27 AM EDT, 05/08/2024 (MT Newswires) -- Bio-Rad Laboratories (BIO) has an average outperform rating and a price target range of $365 to $441, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research...
- --Citigroup Adjusts Price Target on Bio-Rad Laboratories to $300 From $365, from 7:37AM ET on Wednesday May 08, 2024 by MT Newswires
  7:37AM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: BIO
  07:37 AM EDT, 05/08/2024 (MT Newswires) -- Price: 279.11, Change: -0.80, Percent Change: -0.29 ...
May 7, 2024
- Bio-Rad Laboratories Q1 Non-GAAP Earnings, Revenue Decline, from 5:05PM ET on Tuesday May 07, 2024 by MT Newswires
  5:05PM ET on Tuesday May 07, 2024 by MT Newswires
  Companies Mentioned: BIO
  05:05 PM EDT, 05/07/2024 (MT Newswires) -- Bio-Rad Laboratories (BIO) reported Q1 non-GAAP net income Tuesday of $2.29 per diluted share, down from $3.34 a year earlier. Four analysts polled by Capital IQ expected $2.14 per share. Revenue for the qu...

Yesterday
- Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating, from 7:07AM ET on Monday May 13, 2024 by MT Newswires
  7:07AM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: GMED
- Morgan Stanley Lowers Price Target on Stevanato Group to $26 From $30, Keeps Equalweight Rating, from 7:05AM ET on Monday May 13, 2024 by MT Newswires
  7:05AM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: STVN
- Teleflex Publishes 2023 Global Impact Report, from 6:30AM ET on Monday May 13, 2024 by GlobeNewswire
  6:30AM ET on Monday May 13, 2024 by GlobeNewswire
  Companies Mentioned: TFX
May 10, 2024
- Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing, from 4:52PM ET on Friday May 10, 2024 by MT Newswires
  4:52PM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: GMED
- --UBS Adjusts Stevanato Price Target to $24 From $34, Maintains Neutral Rating, from 11:17AM ET on Friday May 10, 2024 by MT Newswires
  11:17AM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: STVN
May 9, 2024
- Sector Update: Health Care Stocks Higher Late Afternoon, from 3:59PM ET on Thursday May 09, 2024 by MT Newswires
  3:59PM ET on Thursday May 09, 2024 by MT Newswires
  Companies Mentioned: IRWD, XFOR, RAPT, STVN
- Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading, from 1:55PM ET on Thursday May 09, 2024 by MT Newswires
  1:55PM ET on Thursday May 09, 2024 by MT Newswires
  Companies Mentioned: IRWD, RPRX, STVN
- Update: Stevanato's Q1 Adjusted Earnings, Revenue Fall; 2024 Guidance Cut; Shares Fall 22%, from 12:45PM ET on Thursday May 09, 2024 by MT Newswires
  12:45PM ET on Thursday May 09, 2024 by MT Newswires
  Companies Mentioned: STVN
- Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating, from 11:57AM ET on Thursday May 09, 2024 by MT Newswires
  11:57AM ET on Thursday May 09, 2024 by MT Newswires
  Companies Mentioned: GMED
- Sector Update: Health Care Stocks Steady Pre-Bell Thursday, from 9:16AM ET on Thursday May 09, 2024 by MT Newswires
  9:16AM ET on Thursday May 09, 2024 by MT Newswires
  Companies Mentioned: TAK, IBB, MRK, XLV, STVN

Bio Rad Laboratories Inc
NYSE:BIOUnited States

Search Criteria

May 8, 2024

UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating, from 10:19AM ET on Wednesday May 08, 2024 by MT Newswires

DJ Bio-Rad Laboratories Is Maintained at Buy by UBS, from 9:37AM ET on Wednesday May 08, 2024 by Dow Jones

RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420, from 8:27AM ET on Wednesday May 08, 2024 by MT Newswires

--Citigroup Adjusts Price Target on Bio-Rad Laboratories to $300 From $365, from 7:37AM ET on Wednesday May 08, 2024 by MT Newswires

May 7, 2024

Bio-Rad Laboratories Q1 Non-GAAP Earnings, Revenue Decline, from 5:05PM ET on Tuesday May 07, 2024 by MT Newswires

Peers Headlines

Yesterday

Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating, from 7:07AM ET on Monday May 13, 2024 by MT Newswires

Morgan Stanley Lowers Price Target on Stevanato Group to $26 From $30, Keeps Equalweight Rating, from 7:05AM ET on Monday May 13, 2024 by MT Newswires

Teleflex Publishes 2023 Global Impact Report, from 6:30AM ET on Monday May 13, 2024 by GlobeNewswire

May 10, 2024

Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing, from 4:52PM ET on Friday May 10, 2024 by MT Newswires

--UBS Adjusts Stevanato Price Target to $24 From $34, Maintains Neutral Rating, from 11:17AM ET on Friday May 10, 2024 by MT Newswires

May 9, 2024

Sector Update: Health Care Stocks Higher Late Afternoon, from 3:59PM ET on Thursday May 09, 2024 by MT Newswires

Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading, from 1:55PM ET on Thursday May 09, 2024 by MT Newswires

Update: Stevanato's Q1 Adjusted Earnings, Revenue Fall; 2024 Guidance Cut; Shares Fall 22%, from 12:45PM ET on Thursday May 09, 2024 by MT Newswires

Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating, from 11:57AM ET on Thursday May 09, 2024 by MT Newswires

Sector Update: Health Care Stocks Steady Pre-Bell Thursday, from 9:16AM ET on Thursday May 09, 2024 by MT Newswires